Erik Ostrowski John's Insider Trades & SAST Disclosures
Erik Ostrowski John's most recent trade in Akebia Therapeutics Inc. was a trade of 292,300 Stock Option (Right to buy) done . Disclosure was reported to the exchange on Jan. 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Erik Ostrowski John.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akebia Therapeutics Inc. | Erik John Ostrowski | SVP, CFO, CBO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 292,300 | 292,300 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | Erik John Ostrowski | SVP, CFO, CBO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 194,900 | 544,900 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc. | Erik John Ostrowski | SVP, CFO, CBO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 500,000 | 500,000 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | Erik John Ostrowski | SVP, CFO, CBO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 350,000 | 350,000 (0%) | 0% | 0 | Common Stock | |
| Tectonic Therapeutic Inc. | Erik John Ostrowski | Interim CEO, President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 40,084 | 120,249 | - | - | Restricted Stock Unit | |
| Tectonic Therapeutic Inc. | Ostrowski John Erik | Interim CEO, President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 40,084 | 42,384 (0%) | 0% | 0 | Common Stock | |
| Tectonic Therapeutic Inc. | Erik Ostrowski John | Interim CEO, President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 01 Feb 2024 | 13,099 | 29,285 (0%) | 0% | 1.2 | 15,745 | Common Stock |
| Tectonic Therapeutic Inc. | Erik John Ostrowski | Interim CEO, President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 70,000 | 70,000 | - | - | Restricted Stock Unit | |
| Tectonic Therapeutic Inc. | Erik John Ostrowski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 160,333 | 160,333 | - | - | Restricted Stock Unit | |
| Tectonic Therapeutic Inc. | Erik John Ostrowski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2022 | 221,000 | 221,000 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Erik John Ostrowski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Erik John Ostrowski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 145,000 | 145,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges